Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Kidney Injury | 28 | 2024 | 1924 | 6.340 |
Why?
|
Hearing Loss | 4 | 2020 | 783 | 1.580 |
Why?
|
Renal Replacement Therapy | 5 | 2023 | 282 | 1.420 |
Why?
|
Ascites | 2 | 2020 | 338 | 1.220 |
Why?
|
Renal Insufficiency, Chronic | 7 | 2024 | 2242 | 1.200 |
Why?
|
Critical Illness | 21 | 2023 | 2723 | 1.190 |
Why?
|
Hyponatremia | 2 | 2020 | 279 | 1.150 |
Why?
|
Cisplatin | 5 | 2024 | 1652 | 1.090 |
Why?
|
Thrombotic Microangiopathies | 1 | 2023 | 123 | 0.790 |
Why?
|
Fanconi Syndrome | 1 | 2022 | 34 | 0.790 |
Why?
|
Intensive Care Units | 14 | 2022 | 3744 | 0.780 |
Why?
|
Neoplasms | 11 | 2024 | 22173 | 0.770 |
Why?
|
Creatinine | 6 | 2024 | 1899 | 0.740 |
Why?
|
Paraproteinemias | 1 | 2024 | 248 | 0.740 |
Why?
|
Diphenhydramine | 1 | 2021 | 63 | 0.740 |
Why?
|
Glomerular Filtration Rate | 8 | 2024 | 2178 | 0.730 |
Why?
|
Water-Electrolyte Balance | 2 | 2020 | 325 | 0.690 |
Why?
|
Hospital Mortality | 14 | 2022 | 5293 | 0.660 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2020 | 109 | 0.640 |
Why?
|
Respiratory Insufficiency | 3 | 2021 | 1230 | 0.600 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 426 | 0.600 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 344 | 0.570 |
Why?
|
Mesothelioma | 1 | 2023 | 807 | 0.560 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2017 | 91 | 0.560 |
Why?
|
Electrolytes | 1 | 2017 | 274 | 0.540 |
Why?
|
Fatigue | 1 | 2023 | 1552 | 0.520 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2024 | 2009 | 0.510 |
Why?
|
Antineoplastic Agents | 6 | 2024 | 13642 | 0.500 |
Why?
|
Acidosis | 1 | 2017 | 268 | 0.500 |
Why?
|
Fructose | 1 | 2017 | 288 | 0.500 |
Why?
|
Hyperammonemia | 1 | 2016 | 76 | 0.500 |
Why?
|
Ammonia | 1 | 2016 | 237 | 0.490 |
Why?
|
Drainage | 1 | 2020 | 1157 | 0.480 |
Why?
|
Bone Density Conservation Agents | 1 | 2022 | 795 | 0.470 |
Why?
|
Duffy Blood-Group System | 1 | 2014 | 58 | 0.470 |
Why?
|
Sodium | 1 | 2020 | 1588 | 0.470 |
Why?
|
Cystatin C | 3 | 2024 | 270 | 0.460 |
Why?
|
Immunotherapy, Adoptive | 3 | 2022 | 1469 | 0.460 |
Why?
|
Blood Group Incompatibility | 1 | 2014 | 135 | 0.450 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2022 | 1405 | 0.440 |
Why?
|
Anemia, Hemolytic | 1 | 2014 | 162 | 0.440 |
Why?
|
Kidney Diseases | 1 | 2024 | 2091 | 0.430 |
Why?
|
Humans | 79 | 2024 | 761596 | 0.390 |
Why?
|
Cohort Studies | 17 | 2024 | 41495 | 0.370 |
Why?
|
Kidney Neoplasms | 3 | 2022 | 4251 | 0.360 |
Why?
|
Echocardiography | 1 | 2023 | 4989 | 0.360 |
Why?
|
Carcinoma, Renal Cell | 3 | 2022 | 3165 | 0.360 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5672 | 0.360 |
Why?
|
Graft vs Host Disease | 1 | 2023 | 3029 | 0.350 |
Why?
|
Prone Position | 2 | 2021 | 196 | 0.340 |
Why?
|
Middle Aged | 40 | 2024 | 220921 | 0.340 |
Why?
|
Renal Dialysis | 3 | 2021 | 1796 | 0.340 |
Why?
|
Erythrocyte Transfusion | 1 | 2014 | 570 | 0.330 |
Why?
|
Carboplatin | 2 | 2023 | 794 | 0.330 |
Why?
|
Internal Medicine | 1 | 2016 | 1051 | 0.330 |
Why?
|
Interleukin-6 | 1 | 2019 | 3208 | 0.330 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1403 | 0.330 |
Why?
|
Kidney | 7 | 2024 | 7048 | 0.320 |
Why?
|
Teaching | 1 | 2016 | 1170 | 0.320 |
Why?
|
Aged | 33 | 2024 | 169310 | 0.320 |
Why?
|
Critical Care | 2 | 2021 | 2697 | 0.310 |
Why?
|
Immunotherapy | 2 | 2021 | 4652 | 0.310 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3826 | 0.310 |
Why?
|
Patient Positioning | 2 | 2021 | 326 | 0.310 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6484 | 0.300 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 1117 | 0.300 |
Why?
|
Adult | 30 | 2024 | 221210 | 0.290 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3615 | 0.280 |
Why?
|
Female | 42 | 2024 | 392705 | 0.280 |
Why?
|
Risk Factors | 18 | 2024 | 74213 | 0.270 |
Why?
|
Adrenal Cortex Hormones | 3 | 2022 | 1881 | 0.270 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4878 | 0.270 |
Why?
|
Incidence | 7 | 2021 | 21355 | 0.260 |
Why?
|
Multiple Myeloma | 1 | 2024 | 5146 | 0.260 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2822 | 0.240 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2472 | 0.240 |
Why?
|
Male | 39 | 2024 | 360846 | 0.230 |
Why?
|
Nephritis, Interstitial | 2 | 2023 | 155 | 0.230 |
Why?
|
Ribose | 1 | 2023 | 63 | 0.220 |
Why?
|
Nephrology | 2 | 2024 | 263 | 0.220 |
Why?
|
Retrospective Studies | 20 | 2024 | 80647 | 0.210 |
Why?
|
Inflammation | 2 | 2021 | 10774 | 0.210 |
Why?
|
Receptors, Interleukin-6 | 2 | 2021 | 225 | 0.210 |
Why?
|
Paraneoplastic Syndromes | 1 | 2024 | 155 | 0.200 |
Why?
|
Communication | 1 | 2016 | 3875 | 0.200 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2021 | 422 | 0.200 |
Why?
|
Bradycardia | 1 | 2023 | 299 | 0.190 |
Why?
|
Respiration, Artificial | 3 | 2023 | 2630 | 0.190 |
Why?
|
Dyspnea | 2 | 2023 | 1347 | 0.190 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2023 | 426 | 0.190 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12463 | 0.190 |
Why?
|
Lung Neoplasms | 2 | 2024 | 13381 | 0.190 |
Why?
|
Ifosfamide | 1 | 2021 | 232 | 0.180 |
Why?
|
Bicarbonates | 1 | 2022 | 292 | 0.180 |
Why?
|
Hyperkalemia | 1 | 2023 | 233 | 0.180 |
Why?
|
United States | 17 | 2022 | 72340 | 0.180 |
Why?
|
Organ Transplantation | 2 | 2021 | 1157 | 0.180 |
Why?
|
Magnesium | 1 | 2023 | 804 | 0.170 |
Why?
|
Pandemics | 6 | 2021 | 8656 | 0.170 |
Why?
|
Health Services Accessibility | 1 | 2017 | 5440 | 0.170 |
Why?
|
Wisconsin | 1 | 2019 | 122 | 0.160 |
Why?
|
Sarcopenia | 1 | 2024 | 372 | 0.160 |
Why?
|
Kidney Tubules | 1 | 2020 | 449 | 0.160 |
Why?
|
Hearing Tests | 1 | 2019 | 121 | 0.160 |
Why?
|
Comorbidity | 7 | 2021 | 10508 | 0.160 |
Why?
|
Kidney Glomerulus | 1 | 2020 | 568 | 0.150 |
Why?
|
ABO Blood-Group System | 1 | 2020 | 380 | 0.150 |
Why?
|
Vomiting | 1 | 2021 | 651 | 0.150 |
Why?
|
Hospitalization | 4 | 2021 | 10721 | 0.150 |
Why?
|
Blood Coagulation Disorders | 1 | 2021 | 350 | 0.140 |
Why?
|
Standard of Care | 1 | 2021 | 551 | 0.140 |
Why?
|
Patients | 1 | 2024 | 907 | 0.140 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2020 | 335 | 0.140 |
Why?
|
Thrombosis | 2 | 2021 | 2942 | 0.140 |
Why?
|
Anticoagulants | 3 | 2021 | 4812 | 0.140 |
Why?
|
Internship and Residency | 1 | 2016 | 5882 | 0.130 |
Why?
|
Arteriosclerosis | 1 | 2020 | 1055 | 0.130 |
Why?
|
Transplantation Conditioning | 1 | 2023 | 1590 | 0.130 |
Why?
|
Survival Rate | 5 | 2021 | 12723 | 0.130 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1164 | 0.130 |
Why?
|
Amino Acids | 1 | 2022 | 1718 | 0.130 |
Why?
|
Paclitaxel | 1 | 2023 | 1732 | 0.130 |
Why?
|
Aged, 80 and over | 8 | 2021 | 58984 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2023 | 2330 | 0.120 |
Why?
|
Nephrectomy | 1 | 2020 | 937 | 0.120 |
Why?
|
Pleural Neoplasms | 1 | 2020 | 609 | 0.120 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2547 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12149 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2020 | 1154 | 0.120 |
Why?
|
Adiposity | 1 | 2024 | 1879 | 0.110 |
Why?
|
Cholecystitis | 1 | 2014 | 180 | 0.110 |
Why?
|
Premedication | 1 | 2014 | 246 | 0.110 |
Why?
|
Hematocrit | 1 | 2014 | 623 | 0.110 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3086 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3206 | 0.100 |
Why?
|
Hepatectomy | 1 | 2015 | 557 | 0.100 |
Why?
|
Birth Weight | 1 | 2020 | 2103 | 0.100 |
Why?
|
Hemorrhage | 2 | 2021 | 3424 | 0.100 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2014 | 411 | 0.090 |
Why?
|
Isoantibodies | 1 | 2014 | 674 | 0.090 |
Why?
|
Domestic Violence | 1 | 2012 | 182 | 0.090 |
Why?
|
Heart Arrest | 1 | 2020 | 1514 | 0.090 |
Why?
|
Child Abuse, Sexual | 1 | 2013 | 403 | 0.090 |
Why?
|
Pilot Projects | 1 | 2023 | 8633 | 0.090 |
Why?
|
Erythropoietin | 1 | 2014 | 719 | 0.090 |
Why?
|
Contrast Media | 1 | 2023 | 5307 | 0.090 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2013 | 294 | 0.080 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2021 | 1462 | 0.080 |
Why?
|
Health Resources | 1 | 2015 | 935 | 0.080 |
Why?
|
Mortality | 1 | 2021 | 2902 | 0.080 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2021 | 2223 | 0.080 |
Why?
|
Self Report | 1 | 2020 | 3725 | 0.080 |
Why?
|
Health Surveys | 1 | 2018 | 4061 | 0.080 |
Why?
|
Drug Resistance | 1 | 2014 | 1596 | 0.080 |
Why?
|
Syndrome | 1 | 2014 | 3267 | 0.080 |
Why?
|
Diagnosis, Differential | 1 | 2023 | 12973 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10554 | 0.070 |
Why?
|
Hospitals | 1 | 2021 | 3883 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9327 | 0.070 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2017 | 1188 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15843 | 0.070 |
Why?
|
Brain Diseases | 1 | 2016 | 1546 | 0.070 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1866 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2947 | 0.070 |
Why?
|
Young Adult | 4 | 2021 | 59260 | 0.070 |
Why?
|
Risk | 1 | 2018 | 9610 | 0.070 |
Why?
|
Hepatitis C, Chronic | 1 | 2014 | 1032 | 0.070 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2571 | 0.070 |
Why?
|
Logistic Models | 1 | 2020 | 13255 | 0.060 |
Why?
|
Adolescent | 5 | 2021 | 88326 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2020 | 4235 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5314 | 0.060 |
Why?
|
Patient Compliance | 2 | 2013 | 2690 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4024 | 0.060 |
Why?
|
Homosexuality, Male | 1 | 2013 | 1334 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2499 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2017 | 1703 | 0.060 |
Why?
|
Prognosis | 3 | 2021 | 29629 | 0.060 |
Why?
|
Algorithms | 2 | 2021 | 14033 | 0.060 |
Why?
|
Acute Disease | 1 | 2014 | 7237 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18399 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2016 | 3600 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20568 | 0.050 |
Why?
|
Viral Load | 1 | 2012 | 3332 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14608 | 0.050 |
Why?
|
Baclofen | 1 | 2023 | 120 | 0.050 |
Why?
|
HIV Infections | 3 | 2014 | 17354 | 0.050 |
Why?
|
Risk Assessment | 1 | 2024 | 23996 | 0.050 |
Why?
|
Digoxin | 1 | 2023 | 246 | 0.050 |
Why?
|
Bilirubin | 1 | 2023 | 436 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11742 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5821 | 0.050 |
Why?
|
Sclerosis | 1 | 2020 | 210 | 0.040 |
Why?
|
Vancomycin | 1 | 2023 | 503 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3204 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12947 | 0.040 |
Why?
|
Thrombophilia | 1 | 2021 | 305 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2020 | 679 | 0.040 |
Why?
|
Prospective Studies | 2 | 2020 | 54423 | 0.040 |
Why?
|
Troponin I | 1 | 2022 | 651 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39106 | 0.040 |
Why?
|
Liposarcoma | 1 | 2020 | 289 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15502 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2020 | 422 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2020 | 417 | 0.030 |
Why?
|
Virginia | 1 | 2015 | 116 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2016 | 26202 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2023 | 1889 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 914 | 0.030 |
Why?
|
Atrophy | 1 | 2020 | 1633 | 0.030 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2020 | 783 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2049 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2020 | 1119 | 0.030 |
Why?
|
Medical Oncology | 1 | 2024 | 2321 | 0.020 |
Why?
|
Unsafe Sex | 1 | 2013 | 238 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26129 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3124 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1752 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3443 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10090 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8527 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9647 | 0.020 |
Why?
|
Risk-Taking | 1 | 2013 | 1038 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 64685 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6426 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2012 | 1436 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7391 | 0.010 |
Why?
|
Forecasting | 1 | 2012 | 2928 | 0.010 |
Why?
|
Health Behavior | 1 | 2012 | 2644 | 0.010 |
Why?
|
Health Status | 1 | 2013 | 4077 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29890 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15733 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 39969 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2015 | 15633 | 0.010 |
Why?
|
Child | 1 | 2013 | 80158 | 0.000 |
Why?
|
Concepts
(236)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(115)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_